Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Best-practice care pathway for improving management of mastitis and breast abscess.

Patani N, MacAskill F, Eshelby S, Omar A, Kaura A, Contractor K, Thiruchelvam P, Curtis S, Main J, Cunningham D, Hogben K, Al-Mufti R, Hadjiminas DJ, Leff DR.

Br J Surg. 2018 Jul 11. doi: 10.1002/bjs.10919. [Epub ahead of print]

PMID:
29993125
2.

Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance.

Martin LA, Ribas R, Simigdala N, Schuster E, Pancholi S, Tenev T, Gellert P, Buluwela L, Harrod A, Thornhill A, Nikitorowicz-Buniak J, Bhamra A, Turgeon MO, Poulogiannis G, Gao Q, Martins V, Hills M, Garcia-Murillas I, Fribbens C, Patani N, Li Z, Sikora MJ, Turner N, Zwart W, Oesterreich S, Carroll J, Ali S, Dowsett M.

Nat Commun. 2017 Nov 30;8(1):1865. doi: 10.1038/s41467-017-01864-y.

3.

Differences in the transcriptional response to fulvestrant and estrogen deprivation in ER-positive breast cancer.

Patani N, Dunbier AK, Anderson H, Ghazoui Z, Ribas R, Anderson E, Gao Q, A'hern R, Mackay A, Lindemann J, Wellings R, Walker J, Kuter I, Martin LA, Dowsett M.

Clin Cancer Res. 2014 Aug 1;20(15):3962-73. doi: 10.1158/1078-0432.CCR-13-1378. Epub 2014 Jun 10.

4.

Effect of aromatase inhibition on functional gene modules in estrogen receptor-positive breast cancer and their relationship with antiproliferative response.

Gao Q, Patani N, Dunbier AK, Ghazoui Z, Zvelebil M, Martin LA, Dowsett M.

Clin Cancer Res. 2014 May 1;20(9):2485-94. doi: 10.1158/1078-0432.CCR-13-2602. Epub 2014 Mar 14.

5.

Understanding response and resistance to oestrogen deprivation in ER-positive breast cancer.

Patani N, Martin LA.

Mol Cell Endocrinol. 2014 Jan 25;382(1):683-694. doi: 10.1016/j.mce.2013.09.038. Epub 2013 Oct 9. Review.

PMID:
24121024
6.

Biomarkers for the clinical management of breast cancer: international perspective.

Patani N, Martin LA, Dowsett M.

Int J Cancer. 2013 Jul;133(1):1-13. doi: 10.1002/ijc.27997. Epub 2013 Feb 8. Review.

7.

Ductal carcinoma in situ: recent advances and future prospects.

Lambert K, Patani N, Mokbel K.

Int J Surg Oncol. 2012;2012:347385. doi: 10.1155/2012/347385. Epub 2012 May 17.

8.

Free flap breast reconstruction consent forms should warn against the potential loss of the internal thoracic artery for coronary artery bypass grafting.

Al-Benna S, Steinstraesser L, Patani N.

Plast Reconstr Surg. 2012 May;129(5):867e-8e. doi: 10.1097/PRS.0b013e31824a9e95. No abstract available.

PMID:
22544135
9.

Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis.

Geyer FC, Lacroix-Triki M, Colombo PE, Patani N, Gauthier A, Natrajan R, Lambros MB, Khalifeh I, Albarracin C, Orru S, MarchiĆ² C, Sapino A, Mackay A, Weigelt B, Schmitt FC, Wesseling J, Sneige N, Reis-Filho JS.

Histopathology. 2012 May;60(6B):E115-30. doi: 10.1111/j.1365-2559.2012.04207.x. Epub 2012 Apr 4.

10.

Histone-modifier gene expression profiles are associated with pathological and clinical outcomes in human breast cancer.

Patani N, Jiang WG, Newbold RF, Mokbel K.

Anticancer Res. 2011 Dec;31(12):4115-25.

PMID:
22199269
11.

Clinical impact of lymph node status in rectal cancer.

Colombo PE, Patani N, Bibeau F, Assenat E, Bertrand MM, Senesse P, Rouanet P.

Surg Oncol. 2011 Dec;20(4):e227-33. doi: 10.1016/j.suronc.2011.08.004. Epub 2011 Sep 10. Review.

PMID:
21911287
12.

Non-existence of caveolin-1 gene mutations in human breast cancer.

Patani N, Lambros MB, Natrajan R, Dedes KJ, Geyer FC, Ward E, Martin LA, Dowsett M, Reis-Filho JS.

Breast Cancer Res Treat. 2012 Jan;131(1):307-10. doi: 10.1007/s10549-011-1761-2. Epub 2011 Sep 11.

PMID:
21909981
13.

The role of caveolin-1 in human breast cancer.

Patani N, Martin LA, Reis-Filho JS, Dowsett M.

Breast Cancer Res Treat. 2012 Jan;131(1):1-15. doi: 10.1007/s10549-011-1751-4. Epub 2011 Sep 8. Review.

PMID:
21901387
14.

High-throughput detection of fusion genes in cancer using the Sequenom MassARRAY platform.

Lambros MB, Wilkerson PM, Natrajan R, Patani N, Pawar V, Vatcheva R, Mansour M, Laschet M, Oelze B, Orr N, Muller S, Reis-Filho JS.

Lab Invest. 2011 Oct;91(10):1491-501. doi: 10.1038/labinvest.2011.110. Epub 2011 Aug 1.

15.

Sentinel lymph node micrometastasis in human breast cancer: an update.

Salhab M, Patani N, Mokbel K.

Surg Oncol. 2011 Dec;20(4):e195-206. doi: 10.1016/j.suronc.2011.06.006. Epub 2011 Jul 23. Review.

PMID:
21788132
16.

Brain-derived neurotrophic factor expression predicts adverse pathological & clinical outcomes in human breast cancer.

Patani N, Jiang WG, Mokbel K.

Cancer Cell Int. 2011 Jul 18;11(1):23. doi: 10.1186/1475-2867-11-23.

17.

Direct evidence for concurrent morphological and genetic heterogeneity in an invasive ductal carcinoma of triple-negative phenotype.

Patani N, Barbashina V, Lambros MB, Gauthier A, Mansour M, Mackay A, Reis-Filho JS.

J Clin Pathol. 2011 Sep;64(9):822-8. doi: 10.1136/jclinpath-2011-200135. Epub 2011 Jun 14.

PMID:
21676924
18.

Clinical significance of sentinel lymph node isolated tumour cells in breast cancer.

Patani N, Mokbel K.

Breast Cancer Res Treat. 2011 Jun;127(2):325-34. doi: 10.1007/s10549-011-1476-4. Epub 2011 Apr 1. Review.

PMID:
21455668
19.

Prognostic implications of carboxyl-terminus of Hsc70 interacting protein and lysyl-oxidase expression in human breast cancer.

Patani N, Jiang W, Newbold R, Mokbel K.

J Carcinog. 2010 Nov 12;9:9. doi: 10.4103/1477-3163.72505.

20.

Ductal carcinoma in-situ: an update for clinical practice.

Patani N, Khaled Y, Al Reefy S, Mokbel K.

Surg Oncol. 2011 Mar;20(1):e23-31. doi: 10.1016/j.suronc.2010.08.007. Epub 2010 Nov 24. Review.

PMID:
21106367
21.

High TIMM17A expression is associated with adverse pathological and clinical outcomes in human breast cancer.

Salhab M, Patani N, Jiang W, Mokbel K.

Breast Cancer. 2012 Apr;19(2):153-60. doi: 10.1007/s12282-010-0228-3. Epub 2010 Oct 23.

PMID:
20972741
22.

The impact of digital mammography on screening a young cohort of women for breast cancer in an urban specialist breast unit.

Perry NM, Patani N, Milner SE, Pinker K, Mokbel K, Allgood PC, Duffy SW.

Eur Radiol. 2011 Apr;21(4):676-82. doi: 10.1007/s00330-010-1968-3. Epub 2010 Oct 1.

PMID:
20886340
23.

Tumour suppressor function of MDA-7/IL-24 in human breast cancer.

Patani N, Douglas-Jones A, Mansel R, Jiang W, Mokbel K.

Cancer Cell Int. 2010 Aug 24;10:29. doi: 10.1186/1475-2867-10-29.

24.

Oncological and aesthetic considerations of conservational surgery for multifocal/multicentric breast cancer.

Patani N, Carpenter R.

Breast J. 2010 May-Jun;16(3):222-32. doi: 10.1111/j.1524-4741.2010.00917.x. Review.

PMID:
20565467
25.

Oncological outcome and patient satisfaction with skin-sparing mastectomy and immediate breast reconstruction: a prospective observational study.

Reefy S, Patani N, Anderson A, Burgoyne G, Osman H, Mokbel K.

BMC Cancer. 2010 Apr 29;10:171. doi: 10.1186/1471-2407-10-171.

26.

The mRNA expression of SATB1 and SATB2 in human breast cancer.

Patani N, Jiang W, Mansel R, Newbold R, Mokbel K.

Cancer Cell Int. 2009 Jul 30;9:18. doi: 10.1186/1475-2867-9-18.

27.

Prognostic utility of glycosyltransferase expression in breast cancer.

Patani N, Jiang W, Mokbel K.

Cancer Genomics Proteomics. 2008 Nov-Dec;5(6):333-40.

28.

Osteopontin expression profiles predict pathological and clinical outcome in breast cancer.

Patani N, Jouhra F, Jiang W, Mokbel K.

Anticancer Res. 2008 Nov-Dec;28(6B):4105-10.

29.

En Garde! A novel splash guard for use in wound irrigation.

Al-Benna S, Al-Ajam Y, Patani N.

Ann R Coll Surg Engl. 2009 Jan;91(1):83-4. No abstract available.

30.

Herceptin and breast cancer: an overview for surgeons.

Patani N, Mokbel K.

Surg Oncol. 2010 Mar;19(1):e11-21. doi: 10.1016/j.suronc.2008.11.001. Epub 2008 Dec 18. Review.

PMID:
19097883
31.

Evidence of a tumour suppressive function of E2F1 gene in human breast cancer.

Worku D, Jouhra F, Jiang GW, Patani N, Newbold RF, Mokbel K.

Anticancer Res. 2008 Jul-Aug;28(4B):2135-9.

32.

Burns is not in the core curricula of medical schools in the United Kingdom.

Al-Benna S, Patani N, Al-Ajam Y.

Burns. 2008 Sep;34(6):902. doi: 10.1016/j.burns.2008.02.008. Epub 2008 Jun 4. No abstract available.

PMID:
18534759
33.

The clinical significance of sentinel lymph node micrometastasis in breast cancer.

Patani N, Mokbel K.

Breast Cancer Res Treat. 2009 Apr;114(3):393-402. doi: 10.1007/s10549-008-0021-6. Epub 2008 Apr 20. Review.

PMID:
18425678
34.

Elevated protein tyrosine phosphatase activity provokes Eph/ephrin-facilitated adhesion of pre-B leukemia cells.

Wimmer-Kleikamp SH, Nievergall E, Gegenbauer K, Adikari S, Mansour M, Yeadon T, Boyd AW, Patani NR, Lackmann M.

Blood. 2008 Aug 1;112(3):721-32. doi: 10.1182/blood-2007-11-121681. Epub 2008 Apr 2.

35.

Changes in breast cancer incidence rates.

Patani N, Jouhra F, Mokbel K.

Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):742. doi: 10.1158/1055-9965.EPI-07-2951. No abstract available.

36.

Osteopontin C mRNA expression is associated with a poor clinical outcome in human breast cancer.

Patani N, Jiang W, Mokbel K.

Int J Cancer. 2008 Jun 1;122(11):2646. doi: 10.1002/ijc.23402. No abstract available.

37.

The utility of MRI for the screening and staging of breast cancer.

Patani N, Mokbel K.

Int J Clin Pract. 2008 Mar;62(3):450-3. doi: 10.1111/j.1742-1241.2007.01677.x. Epub 2008 Jan 12. Review.

PMID:
18201177
38.

Oncological safety and patient satisfaction with skin-sparing mastectomy and immediate breast reconstruction.

Patani N, Devalia H, Anderson A, Mokbel K.

Surg Oncol. 2008 Aug;17(2):97-105. Epub 2008 Feb 21.

PMID:
18093828
39.

Oncological and aesthetic considerations of skin-sparing mastectomy.

Patani N, Mokbel K.

Breast Cancer Res Treat. 2008 Oct;111(3):391-403. Epub 2007 Oct 28. Review.

PMID:
17965954
40.

Current management of DCIS: a review.

Patani N, Cutuli B, Mokbel K.

Breast Cancer Res Treat. 2008 Sep;111(1):1-10. Epub 2007 Sep 28. Review.

PMID:
17902049
41.

Predictors of axillary lymph node metastasis in breast cancer: a systematic review.

Patani NR, Dwek MV, Douek M.

Eur J Surg Oncol. 2007 May;33(4):409-19. Epub 2006 Nov 22. Review.

PMID:
17125963
42.

Mapping loss of heterozygosity in normal human breast cells from BRCA1/2 carriers.

Clarke CL, Sandle J, Jones AA, Sofronis A, Patani NR, Lakhani SR.

Br J Cancer. 2006 Aug 21;95(4):515-9. Epub 2006 Aug 1.

43.

'Nipped in the Budd': hepatic venous outflow obstruction in evolution.

Karageorgiou H, Mookerjee RP, Patani NR, Pachiadakis I, Usiskin SI, Gillams A, Lees WR, Williams R, Douek M, Jalan R.

Eur J Gastroenterol Hepatol. 2005 Jan;17(1):65-8.

PMID:
15647643

Supplemental Content

Loading ...
Support Center